First Trust Advisors
DNLI icon

First Trust Advisors’s Denali Therapeutics DNLI Stock Holding History

First Trust Advisors’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-65,442
Closed -$1.33M – 2556
2024
Q4 		$1.33M Buy
65,442
+47,308
+261% +$1.21M ﹤0.01% 1961
2024
Q3 		$528K Sell
18,134
-1,116
-6% -$27.7K ﹤0.01% 2164
2024
Q2 		$447K Buy
+19,250
New +$370K ﹤0.01% 2150
2022
Q2 		– Sell
-14,224
Closed -$458K – 2513
2022
Q1 		$458K Sell
14,224
-923
-6% -$31.8K ﹤0.01% 2274
2021
Q4 		$676K Sell
15,147
-65,306
-81% -$3.09M ﹤0.01% 2199
2021
Q3 		$4.06M Buy
80,453
+19,135
+31% +$1.08M ﹤0.01% 1447
2021
Q2 		$4.81M Buy
61,318
+17,547
+40% +$1.09M 0.01% 1385
2021
Q1 		$2.5M Sell
43,771
-135,633
-76% -$9.08M ﹤0.01% 1633
2020
Q4 		$15M Buy
179,404
+39,873
+29% +$2.41M 0.02% 709
2020
Q3 		$5M Buy
139,531
+98,673
+242% +$2.97M 0.01% 965
2020
Q2 		$988K Buy
40,858
+7,979
+24% +$188K ﹤0.01% 1738
2020
Q1 		$576K Buy
+32,879
New +$686K ﹤0.01% 1880
2019
Q4 		– Sell
-72,102
Closed -$1.1M – 2399
2019
Q3 		$1.1M Buy
+72,102
New +$1.38M ﹤0.01% 1829

Other funds holding DNLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Trust Advisors's DNLI Position: Q1 2025 in Review

First Trust Advisors sold out of Denali Therapeutics (DNLI) in Q1 2025, closing a stake of 65,442 shares — an estimated $1.33M sold.

First Trust Advisors first reported a position in DNLI in Q3 2019 and held it in 13 quarters. The position peaked at $15M in Q4 2020. 222 funds tracked by Wall St. Rank hold DNLI as of Q1 2025.

  • First Trust Advisors reported no remaining Denali Therapeutics position as of Q1 2025 after selling out during the quarter.
  • First Trust Advisors sold 65,442 Denali Therapeutics shares in Q1 2025, an estimated $1.33M.
  • First Trust Advisors first reported a position in Denali Therapeutics in Q3 2019 and held it in 13 quarters.
  • First Trust Advisors's Denali Therapeutics position peaked at $15M in Q4 2020.
  • 222 funds tracked by Wall St. Rank held Denali Therapeutics as of Q1 2025.

Based on First Trust Advisors's 13F filing for Q1 2025, filed 14 May 2025.